SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VVUS: VIVUS INC. (NASDAQ)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: blankmind who wrote (19108)2/25/1999 7:20:00 PM
From: VLAD  Read Replies (1) of 23519
 
<<2% market share>>

Try a lot higher than 2% especially if you don't include the Viagra scripts written for either recreational use or for purely erection enhancement. 10% minimal market share which equates to 4 to 5 hundred million in product sales in a maturing global market. If realized that should put Vivus back up to the $25.00 level. This doesn't include the effect a marketable product using gene therapy might add to the value of the stock.

The dummies gave away a lot of shares into the shorts cover allowing allowing hedged positions to cover their short positions into the open market. They still hold their long positions and the agenda to keep the stock price depressed dissipates as the short interest decreases.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext